Number of Shares
13,374.00
Current Holdings Value*
$2.22 Mil
% of Portfolio
5.12%
Total Estimate Gain
$126,320.64
% of Total Estimate Gain
4.48%

AlphaCentric Life Sciences and Healthcare Fund's Johnson & Johnson Holding Summary

As of 2025-03-31, AlphaCentric Life Sciences and Healthcare Fund held 13,374.00 shares of Johnson & Johnson(JNJ), totaling $2.22 Mil. This investment constitutes 5.12% of their stock portfolio, and AlphaCentric Life Sciences and Healthcare Fund now holds 0% of the outstanding Johnson & Johnson(JNJ) stock.

The initial trade took place in 2020Q1. And since then AlphaCentric Life Sciences and Healthcare Fund has made 2 purchases of JNJ, at an average price of $154.81, for a total of 18,226.00 shares. In addition, there have been 2 sales at an average price of $156.36 for 4,852.00 shares. Based on historical transaction data and JNJ's current price of $163.70, AlphaCentric Life Sciences and Healthcare Fund's estimated gain on his JNJ holdings is $126,320.64, reflecting a 4.48% gain to date.

AlphaCentric Life Sciences and Healthcare Fund JNJ ($163.70) Holding Chart

AlphaCentric Life Sciences and Healthcare Fund JNJ ($163.70) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1